OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $5,609,700 Invested

2024

PharmatrophiX

Anne Longo, BA

Phase 2b/3 trial of LM11A-31-BHS for Alzheimer's Disease

  • Funding Amount: $5,609,700
  • Organization Type: Biotechnology/For Profit
  • Program: Clinical
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Active